NASDAQ · PRAX
Praxis Precision Medicines, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PRAX: Nov 09, 2026
Praxis Precision Medicines, Inc. Common Stock is expected to report earnings on 11/09/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $-3.68. The reported EPS for the same quarter last year was $-3.36.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-3.68 | $-3.22 | $-4.23 | 8 |
| Dec 2026 | $-4.26 | $-3.37 | $-5.17 | 8 |
| Mar 2027 | $-3.94 | $-2.98 | $-4.75 | 5 |
| Jun 2027 | $-3.46 | $-2.14 | $-4.59 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · BNK Invest · The Motley Fool · Zacks- Fintel · Oct 16, 8:32 PM EDTUBS Initiates Coverage of Praxis Precision Medicines with BuyFintel reports that on October 15, 2026, UBS initiated coverage of Praxis Precision Medicines (NASDAQGS:PRAX) with a Buy recommendation. On the same day, HC Wainwright & Co. reiterated its Buy rating for the company.Prior to this rating action, the stock closed at $239.02 on
- Fintel · Oct 16, 8:22 PM EDTJP Morgan Initiates Coverage of Praxis Precision Medicines at OverweightFintel reports that on October 16, 2026, JP Morgan initiated coverage of Praxis Precision Medicines (NASDAQGS:PRAX) with a Overweight recommendation.The stock closed at $241.78 on October 16, 2026, following a pre-action close of $248.24 on October 15, 2026. This represents a one
- BNK Invest · Sep 28, 3:36 PM EDTNotable Monday Option Activity: PSIX, UVE, PRAXAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Power Solutions International Inc (Symbol: PSIX), where a total of 2,200 contracts have traded so far, representing approximately 220,000 underlying shares. That amounts
- The Motley Fool · Aug 13, 12:29 PM EDTPraxis (PRAX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 11, 10:01 AM EDT4 Biotech Stocks With Major Second-Half Pipeline Catalysts This YearVertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face major 2026 catalysts, from FDA decisions to late-stage readouts.
- RTTNews · Aug 7, 1:25 PM EDTShow Me The Money: After An 800%+ Gain, PRAX Enters A High-Stakes Stretch(RTTNews) – With four late-stage assets, three FDA Breakthrough Therapy Designations, and two upcoming PDUFA decisions, Praxis Precision Medicines (PRAX), a CNS precision neuroscience biopharmaceutical company, is entering a defining chapter.
- MarketBeat · Aug 7, 4:04 AM EDTPraxis Precision Medicines Q2 Earnings Call HighlightsPraxis Precision Medicines (NASDAQ:PRAX) said it is preparing for potential commercial launches of ulixacaltamide for essential tremor and relutrigine for SCN2A- and SCN8A-related developmental and epileptic encephalopathies, or DEEs, as both new drug applications remain under FD
- RTTNews · Jun 30, 4:05 AM EDTFDA Extends Praxis' Relutrigine NDA Review; New PDUFA Date Set For December 27,2026(RTTNews) – Praxis Precision Medicines, Inc. (PRAX), a clinical-stage neuroscience biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period by three months for its New Drug Application for Relutrigine in the treatment of
- RTTNews · Jun 22, 11:49 AM EDTPraxis Gains After FDA Grants Breakthrough Therapy Designation To Elsunersen For SCN2A-DEE(RTTNews) – Praxis Precision Medicines, Inc. (PRAX) rose in trading after the U.S. FDA granted Breakthrough Therapy Designation to Elsunersen for the treatment of seizures associated with SCN2A Developmental and Epileptic Encephalopathy (SCN2A-DEE). The designation follows encour
- RTTNews · Jun 4, 9:20 AM EDTWedbush Analyst Ratings On PRAX, IDYA, EWTX, JADE(RTTNews) – Wedbush Cuts Praxis Price Target to $162 After POWER1 Miss
- Barchart · Jun 3, 2:47 PM EDTStock Indexes Post New Record Highs Amid AI EnthusiasmThe S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.13%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.48%. June E-mini S&P futures (ESM26 ) rose +0.14%, and June E-mini Nasdaq futures…
- Barchart · Jun 2, 7:44 PM EDTStocks Push Higher on US Labor Market Strength and AI SpendingThe S&P 500 Index ($SPX ) (SPY ) today is up +0.24%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.29%. June E-mini S&P futures (ESM26 ) are up +0.20%, and June E-mini Nasdaq futures…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Praxis Precision Medicines, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.